Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024904
Filing Date
2019-05-09
Accepted
2019-05-09 16:30:57
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv520162_10q.htm 10-Q 648961
2 EXHIBIT 31.1 tv520162_ex31-1.htm EX-31.1 8015
3 EXHIBIT 32.1 tv520162_ex32-1.htm EX-32.1 3791
  Complete submission text file 0001144204-19-024904.txt   6523794

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT asmb-20190331.xml EX-101.INS 2102318
5 XBRL TAXONOMY EXTENSION SCHEMA asmb-20190331.xsd EX-101.SCH 36313
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20190331_cal.xml EX-101.CAL 39738
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20190331_def.xml EX-101.DEF 256412
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20190331_lab.xml EX-101.LAB 319381
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20190331_pre.xml EX-101.PRE 302389
Mailing Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 19811034
SIC: 2834 Pharmaceutical Preparations